GlassScriptPhysician profile
John M Martens
NPI 1699852368
$475.78
in general payments reported to CMS, 2019-2025
11 companies · $26.36 in 2025
The $26.36 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $199 · 2020: $48.73 · 2021: $70.18 · 2022: $47.43 · 2023: $52.39 · 2024: $32.09 · 2025: $26.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $110.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $139.06 | 2019 | |
| Novocure INC. | $132.67 | 2019-2022 | |
| Reflexion Medical, INC. | $37.03 | 2023 | Reflexion Medical Radiotherapy System |
| Dendreon Pharmaceuticals LLC | $32.09 | 2024 | Provenge |
| Astrazeneca Pharmaceuticals LP | $31.09 | 2020 | |
| Teleflex LLC | $26.36 | 2025 | Barrigel |
| Medtronic, INC. | $23.90 | 2022 | |
| Boston Scientific Corporation | $15.36 | 2023 | Spaceoar Vue System - 10ml |
| Myriad Genetic Laboratories, INC. | $14.76 | 2021 | |
| Elekta, INC. | $12.66 | 2019 | |
| Medtronic USA, INC. | $10.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Martens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.